| Product NDC: | 0067-2045 |
| Proprietary Name: | EXCEDRIN |
| Non Proprietary Name: | Acetaminophine, caffeine |
| Active Ingredient(s): | 500; 65 mg/1; mg/1 & nbsp; Acetaminophine, caffeine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0067-2045 |
| Labeler Name: | Novartis Consumer Health, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part343 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20051031 |
| Package NDC: | 0067-2045-02 |
| Package Description: | 2 TABLET, FILM COATED in 1 POUCH (0067-2045-02) |
| NDC Code | 0067-2045-02 |
| Proprietary Name | EXCEDRIN |
| Package Description | 2 TABLET, FILM COATED in 1 POUCH (0067-2045-02) |
| Product NDC | 0067-2045 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Acetaminophine, caffeine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20051031 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Novartis Consumer Health, Inc. |
| Substance Name | ACETAMINOPHEN; CAFFEINE |
| Strength Number | 500; 65 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |